Role of Plant-Derived Flavonoids in Cancer Treatment

References

• Dintcheva NT, D’Anna F. Anti-/pro-oxidant behavior of naturally occurring molecules in polymers and biopolymers: A brief review. ACS Sustainable Chem Eng. 2019;7(15):12656–70. doi:10.1021/acssuschemeng.9b02127
   Web of Science ®Google Scholar
• Tohge T, de Souza LP, Fernie AR. Current understanding of the pathways of flavonoid biosynthesis in model and crop plants. J Exp Bot. 2018;69(18):4497.
   PubMed Web of Science ®Google Scholar
• Tarahovsky YS, Kim YA, Yagolnik EA, Muzafarov EN. Flavonoid-membrane interactions: Involvement of flavonoid-metal complexes in raft signaling. BBA-Biomemberanes. 2014;1838(5):1235–46.
   Google Scholar
• Jiang W, Hu M. Mutual interactions between flavonoids and enzymatic and transporter elements responsible for flavonoid disposition via phase ii metabolic pathways. RSC Adv. 2012;2(21):7948–63. doi:10.1039/C2RA01369J
   PubMed Web of Science ®Google Scholar
• Tiwari P. Role of flavonoids in dna damage and carcinogenesis prevention. J Carcinog Mutagen. 2017;8(4):1–6. doi:10.4172/2157-2518.1000297
   Google Scholar
• Ballard C, Maróstica M. Health Benefits of Flavonoids. Bioactive compounds. Chapter 10; 2019; 185–201. p.
   Google Scholar
• Tiwari P, Kumar A, Ali M, Mishra KP. Radioprotection of plasmid and cellular dna and swiss mice by silibinin. Mutat Res/Genet Toxicol Environ Mutag. 2010;695(1–2):55–60. doi:10.1016/j.mrgentox.2009.11.007
   PubMed Web of Science ®Google Scholar
• Kaurinovic B, Vastag G. 2019. Flavonoids and phenolic acids as potential natural antioxidants.
   Google Scholar
• Procházková D, Boušová I, Wilhelmová N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia. 2011;82(4):513–23. doi:10.1016/j.fitote.2011.01.018
   PubMed Web of Science ®Google Scholar
• Firuzi O, Lacanna A, Petrucci R, Marrosu G, Saso L. Evaluation of the antioxidant activity of flavonoids by ‘ferric reducing antioxidant power’ assay and cyclic voltammetry. Biochim Biophys Acta. 2005;1721(1-3):174–84. doi:10.1016/j.bbagen.2004.11.001
   PubMed Web of Science ®Google Scholar
• Rahal A, Kumar A, Singh V, Yadav B, Tiwari R, Chakraborty S, Dhama K. Oxidative stress, prooxidants, and antioxidants: The interplay. Biomed Res Int. 2014;2014:761264–doi:10.1155/2014/761264
   PubMed Web of Science ®Google Scholar
• Chobot V, Hadacek F. Exploration of pro-oxidant and antioxidant activities of the flavonoid myricetin. Redox Rep. 2011;16(6):242–7. doi:10.1179/1351000211Y.0000000015
   PubMed Web of Science ®Google Scholar
• Simunkova M, Barbierikova Z, Jomova K, Hudecova L, Lauro P, Alwasel SH, Alhazza I, Rhodes CJ, Valko M. Antioxidant vs. Prooxidant properties of the flavonoid, kaempferol, in the presence of cu(ii) ions: A ros-scavenging activity, fenton reaction and dna damage study. IJMS. 2021;22(4):1619. doi:10.3390/ijms22041619
   Web of Science ®Google Scholar
• Garg AK, Buchholz TA, Aggarwal BB. Chemosensitization and radiosensitization of tumors by plant polyphenols. Antioxid Redox Signal. 2005;7(11–12):1630–47. doi:10.1089/ars.2005.7.1630
   PubMed Web of Science ®Google Scholar
• Gibellini L, Pinti M, Nasi M, De Biasi S, Roat E, Bertoncelli L, Cossarizza A. Interfering with ros metabolism in cancer cells: The potential role of quercetin. Cancers (Basel). 2010;2(2):1288–311. doi:10.3390/cancers2021288
   PubMedGoogle Scholar
• Kerimi A, Williamson G. Differential impact of flavonoids on redox modulation, bioenergetics, and cell signaling in normal and tumor cells: A comprehensive review. Antioxid Redox Signal. 2018;29(16):1633–59. doi:10.1089/ars.2017.7086
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Yuan B, Hu X, Okazaki M. Chemopreventive and anticancer activity of flavonoids and its possibility for clinical use by combining with conventional chemotherapeutic agents. Am J Cancer Res. 2019;9(8):1517–35.
   PubMed Web of Science ®Google Scholar
• Tiwari P, Mishra KP. Flavonoids sensitize tumor cells to radiation: Molecular mechanisms and relevance to cancer radiotherapy. Int J Radiat Biol. 2020;96(3):360–9. doi:10.1080/09553002.2020.1694193
   PubMed Web of Science ®Google Scholar
• Bisol Â, Campos PS, Lamers ML. Flavonoids as anticancer therapies: A systematic review of clinical trials. Phytother Res. 2020;34(3):568–82. doi:10.1002/ptr.6551
   PubMed Web of Science ®Google Scholar
• George VC, Dellaire G, Rupasinghe HPV. Plant flavonoids in cancer chemoprevention: Role in genome stability. J Nutr Biochem. 2017;45:1–14. doi:10.1016/j.jnutbio.2016.11.007
   PubMed Web of Science ®Google Scholar
• Jeong J-M, Choi C-H, Kang S-K, Lee I-H, Lee J-Y, Jung H. Antioxidant and chemosensitizing effects of flavonoids with hydroxy and/or methoxy groups and structure-activity relationship. J Pharm Pharm Sci. 2007;10(4):537–46. doi:10.18433/j3kw2z
   PubMed Web of Science ®Google Scholar
• Tiwari P, Kumar A, Balakrishnan S, Kushwaha HS, Mishra KP. Silibinin-induced apoptosis in mcf7 and t47d human breast carcinoma cells involves caspase-8 activation and mitochondrial pathway. Cancer Invest. 2011;29(1):12–20. doi:10.3109/07357907.2010.535053
   PubMed Web of Science ®Google Scholar
• Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, Raghavan SC. Quercetin, a natural flavonoid interacts with dna, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep. 2016;6(1):24049. doi:10.1038/srep24049
   PubMed Web of Science ®Google Scholar
• Batra P, Sharma AK. Anti-cancer potential of flavonoids: Recent trends and future perspectives. 3 Biotech. 2013;3(6):439–59. doi:10.1007/s13205-013-0117-5
   PubMedGoogle Scholar
• Ye Q, Liu K, Shen Q, Li Q, Hao J, Han F, Jiang R-W. Reversal of multidrug resistance in cancer by multi-functional flavonoids. Front Oncol. 2019;9:487–doi:10.3389/fonc.2019.00487
   PubMed Web of Science ®Google Scholar
• Ponte LG, Pavan IC, Mancini MC, da Silva LG, Morelli AP, Severino MB, Bezerra RM, Simabuco FM. The hallmarks of flavonoids in cancer. Molecules. 2021;26(7):2029. doi:10.3390/molecules26072029
   PubMed Web of Science ®Google Scholar
• Jiang W, Xia T, Liu C, Li J, Zhang W, Sun C. Remodeling the epigenetic landscape of cancer—application potential of flavonoids in the prevention and treatment of cancer. Front Oncol. 2021;11:705903. doi:10.3389/fonc.2021.705903
   PubMed Web of Science ®Google Scholar
• Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S. Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigenetics. 2015;7(1):64. doi:10.1186/s13148-015-0095-z
   PubMed Web of Science ®Google Scholar
• To KKW, Cho WCS. Flavonoids overcome drug resistance to cancer chemotherapy by epigenetically modulating multiple mechanisms. Curr Cancer Drug Targets. 2021;21(4):289–305. doi:10.2174/1568009621666210203111220
   PubMed Web of Science ®Google Scholar
• Srivastava SK, Bhardwaj A, Arora S, Tyagi N, Singh S, Andrews J, McClellan S, Wang B, Singh AP. Microrna-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. Br J Cancer. 2015;113(4):660–8. doi:10.1038/bjc.2015.252
   PubMed Web of Science ®Google Scholar
• Phi LTH, Sari IN, Yang Y-G, Lee S-H, Jun N, Kim KS, Lee YK, Kwon HY. Cancer stem cells (cscs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018;2018:5416923–doi:10.1155/2018/5416923
   PubMed Web of Science ®Google Scholar
• Kandhari K, Agraval H, Sharma A, Yadav U, Singh R. Flavonoids and Cancer Stem Cells Maintenance and Growth. In: Rani V, Yadav U, editors. Functional Food and Human Health. 2018;587–622. p.
   Google Scholar
• Mirossay L, Varinská L, Mojžiš J. Antiangiogenic effect of flavonoids and chalcones: An update. IJMS. 2017;19(1):27. doi:10.3390/ijms19010027
   Web of Science ®Google Scholar
• Liskova A, Samec M, Koklesova L, Brockmueller A, Zhai K, Abdellatif B, Siddiqui M, Biringer K, Kudela E, Pec M, et al. Flavonoids as an effective sensitizer for anti-cancer therapy: Insights into multi-faceted mechanisms and applicability towards individualized patient profiles. EPMA Journal. 2021;12(2):155–76. doi:10.1007/s13167-021-00242-5
   PubMed Web of Science ®Google Scholar
• Barrera G, Cucci MA, Grattarola M, Dianzani C, Muzio G, Pizzimenti S. Control of oxidative stress in cancer chemoresistance: Spotlight on nrf2 role. Antioxidants. 2021;10(4):510. doi:10.3390/antiox10040510
   Web of Science ®Google Scholar
• L. Suraweera T, Rupasinghe HPV, Dellaire G, Xu Z. Regulation of nrf2/are pathway by dietary flavonoids: A friend or foe for cancer management? Antioxidants. 2020;9(10):973. doi:10.3390/antiox9100973
   Web of Science ®Google Scholar
• Shen M, Chan TH, Dou QP. Targeting tumor ubiquitin-proteasome pathway with polyphenols for chemosensitization. Anticancer Agents Med Chem. 2012;12(8):891–901. doi:10.2174/187152012802649978
   PubMed Web of Science ®Google Scholar
• Kaur H, Kaur G. A critical appraisal of solubility enhancement techniques of polyphenols. J Pharm (Cairo). 2014;2014:180845. doi:10.1155/2014/180845
   PubMedGoogle Scholar
• Bilia A, Isacchi B, Righeschi C, Guccione C, Maria C, Bergonzi M. Flavonoids loaded in nanocarriers: An opportunity to increase oral bioavailability and bioefficacy. FNS. 2014;05(13):1212–327. doi:10.4236/fns.2014.513132
   Google Scholar
• Forbes-Hernández TY. Berries polyphenols: Nano-delivery systems to improve their potential in cancer therapy. JBR. 2020;10(1):45–60. doi:10.3233/JBR-200547
   Web of Science ®Google Scholar
• Zhao J, Yang J, Xie Y. Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int J Pharm. 2019;570:118642. doi:10.1016/j.ijpharm.2019.118642
   PubMed Web of Science ®Google Scholar
• Aiello P, Consalvi S, Poce G, Raguzzini A, Toti E, Palmery M, Biava M, Bernardi M, Kamal MA, Perry G, et al. Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy. Semin Cancer Biol. 2021;69:150–65. doi:10.1016/j.semcancer.2019.08.029
   PubMed Web of Science ®Google Scholar
• Thilakarathna SH, Rupasinghe HPV. Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients. 2013;5(9):3367–87. doi:10.3390/nu5093367
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MDP, Acosta-Torres LS, Diaz-Torres LA, Grillo R, Swamy MK, Sharma S, et al. Nano based drug delivery systems: Recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Vaiserman A, Koliada A, Zayachkivska A, Lushchak O. Nanodelivery of natural antioxidants: An anti-aging perspective. Front Bioeng Biotechnol. 2020;7:447. doi:10.3389/fbioe.2019.00447
   PubMed Web of Science ®Google Scholar
• Khan H, Ullah H, Martorell M, Valdes SE, Belwal T, Tejada S, Sureda A, Kamal MA. Flavonoids nanoparticles in cancer: Treatment, prevention and clinical prospects. Semin Cancer Biol. 2021;69:200–11. doi:10.1016/j.semcancer.2019.07.023
   PubMed Web of Science ®Google Scholar
• Li K, Teng C, Min Q. Advanced nanovehicles-enabled delivery systems of epigallocatechin gallate for cancer therapy. Front Chem. 2020;8:573297. doi:10.3389/fchem.2020.573297
   PubMed Web of Science ®Google Scholar
• Hu K, Miao L, Goodwin TJ, Li J, Liu Q, Huang L. Quercetin remodels the tumor microenvironment to improve the permeation, retention, and antitumor effects of nanoparticles. ACS Nano. 2017;11(5):4916–25. doi:10.1021/acsnano.7b01522
   PubMed Web of Science ®Google Scholar
• Wang G, Zhang D, Yang S, Wang Y, Tang Z, Fu X. Co-administration of genistein with doxorubicin-loaded polypeptide nanoparticles weakens the metastasis of malignant prostate cancer by amplifying oxidative damage. Biomater Sci. 2018;6(4):827–35. doi:10.1039/c7bm01201b
   PubMed Web of Science ®Google Scholar
• Huang C, Chen T, Zhu D, Huang Q. Enhanced tumor targeting and radiotherapy by quercetin loaded biomimetic nanoparticles. Front Chem. 2020;8:225. doi:10.3389/fchem.2020.00225
   PubMed Web of Science ®Google Scholar
• Alharbi WS, Almughem FA, Almehmady AM, Jarallah SJ, Alsharif WK, Alzahrani NM, Alshehri AA. Phytosomes as an emerging nanotechnology platform for the topical delivery of bioactive phytochemicals. Pharmaceutics. 2021;13(9):1475. doi:10.3390/pharmaceutics13091475
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: Progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi:10.1038/nrc.2016.108
   PubMed Web of Science ®Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–24. doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Mladenka P, Macáková K, Zatloukalová L, Reháková Z, Singh BK, Prasad AK, Parmar VS, Jahodár L, Hrdina R, Saso L. In vitro interactions of coumarins with iron. Biochimie. 2010;92(9):1108–14. doi:10.1016/j.biochi.2010.03.025
   PubMed Web of Science ®Google Scholar
• Brillo V, Chieregato L, Leanza L, Muccioli S, Costa R. Mitochondrial dynamics, ros, and cell signaling: A blended overview. Life. 2021;11(4):332. doi:10.3390/life11040332
   PubMedGoogle Scholar
• Tavsan Z, Kayali HA. Flavonoids showed anticancer effects on the ovarian cancer cells: Involvement of reactive oxygen species, apoptosis, cell cycle and invasion. Biomed Pharmacother. 2019;116:109004. doi:10.1016/j.biopha.2019.109004
   PubMed Web of Science ®Google Scholar
• NavaneethaKrishnan S, Rosales JL, Lee K-Y. Ros-mediated cancer cell killing through dietary phytochemicals. Oxid Med Cell Longev. 2019;2019:9051542. doi:10.1155/2019/9051542
   PubMed Web of Science ®Google Scholar
• Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A. Ros in cancer therapy: The bright side of the moon. Exp Mol Med. 2020;52(2):192–203. doi:10.1038/s12276-020-0384-2
   PubMed Web of Science ®Google Scholar
• Ranneh Y, Ali F, Akim AM, Hamid HA, Khazaai H, Fadel A. Crosstalk between reactive oxygen species and pro-inflammatory markers in developing various chronic diseases: A review. Appl Biol Chem. 2017;60(3):327–38. doi:10.1007/s13765-017-0285-9
   Web of Science ®Google Scholar
• Pan M-H, Lai C-S, Ho C-T. Anti-inflammatory activity of natural dietary flavonoids. Food Funct. 2010;1(1):15–31. doi:10.1039/c0fo00103a
   PubMed Web of Science ®Google Scholar
• Sanhueza C, Wehinger S, Castillo Bennett J, Valenzuela M, Owen GI, Quest AFG. The twisted survivin connection to angiogenesis. Mol Cancer. 2015;14(1):198. doi:10.1186/s12943-015-0467-1
   PubMed Web of Science ®Google Scholar
• Aggarwal V, Tuli HS, Varol A, Thakral F, Yerer MB, Sak K, Varol M, Jain A, Khan MA, Sethi G. Role of reactive oxygen species in cancer progression: Molecular mechanisms and recent advancements. Biomolecules. 2019;9(11):735. doi:10.3390/biom9110735
   PubMed Web of Science ®Google Scholar
• Li G, Ding K, Qiao Y, Zhang L, Zheng L, Pan T, Zhang L. Flavonoids regulate inflammation and oxidative stress in cancer. Molecules. 2020;25(23):5628. doi:10.3390/molecules25235628
   PubMed Web of Science ®Google Scholar
• Subbaraj GK, Kumar YS, Kulanthaivel L. Antiangiogenic role of natural flavonoids and their molecular mechanism: An update. Egypt J Intern Med. 2021;33(1):29. doi:10.1186/s43162-021-00056-x
   Google Scholar
• Shi Y, Nikulenkov F, Zawacka-Pankau J, Li H, Gabdoulline R, Xu J, Eriksson S, Hedström E, Issaeva N, Kel A, et al. Ros-dependent activation of jnk converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis. Cell Death Differ. 2014;21(4):612–23. doi:10.1038/cdd.2013.186
   PubMed Web of Science ®Google Scholar
• Redza-Dutordoir M, Averill-Bates DA. Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta (BBA) - Mol Cell Res. 2016;1863(12):2977–92. doi:10.1016/j.bbamcr.2016.09.012
   PubMed Web of Science ®Google Scholar
• Eghbaliferiz S, Iranshahi M. Prooxidant activity of polyphenols, flavonoids, anthocyanins and carotenoids: Updated review of mechanisms and catalyzing metals. Phytother Res. 2016;30(9):1379–91. doi:10.1002/ptr.5643
   PubMed Web of Science ®Google Scholar
• Rajabi S, Maresca M, Yumashev AV, Choopani R, Hajimehdipoor H. The most competent plant-derived natural products for targeting apoptosis in cancer therapy. Biomolecules. 2021;11(4):534. doi:10.3390/biom11040534
   PubMed Web of Science ®Google Scholar
• Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, Liang X. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37(1):266– doi:10.1186/s13046-018-0909-x
   PubMed Web of Science ®Google Scholar
• Sak K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn Rev. 2014;8(16):122–46. doi:10.4103/0973-7847.134247
   PubMedGoogle Scholar
• Tiwari P, Mishra K. Silibinin in cancer therapy: A promising prospect. Cancer Res Front. 2015;1(3):303–18. doi:10.17980/2015.303
   Google Scholar
• You Y, He Q, Lu H, Zhou X, Chen L, Liu H, Lu Z, Liu D, Liu Y, Zuo D, et al. Silibinin induces g2/m cell cycle arrest by activating drp1-dependent mitochondrial fission in cervical cancer. Front Pharmacol. 2020;11:271– doi:10.3389/fphar.2020.00271
   PubMed Web of Science ®Google Scholar
• Deep G, Agarwal R. Antimetastatic efficacy of silibinin: Molecular mechanisms and therapeutic potential against cancer. Cancer Metastasis Rev. 2010;29(3):447–63. doi:10.1007/s10555-010-9237-0
   PubMed Web of Science ®Google Scholar
• Lin CH, Li CH, Liao PL, Tse LS, Huang WK, Cheng HW, Cheng YW. Silibinin inhibits vegf secretion and age-related macular degeneration in a hypoxia-dependent manner through the pi-3 kinase/akt/mtor pathway. Br J Pharmacol. 2013;168(4):920–31. doi:10.1111/j.1476-5381.2012.02227.x
   PubMed Web of Science ®Google Scholar
• Hou X, Du H, Quan X, Shi L, Zhang Q, Wu Y, Liu Y, Xiao J, Li Y, Lu L, et al. Silibinin inhibits nsclc metastasis by targeting the egfr/lox pathway. Front Pharmacol. 2018;9:21. doi:10.3389/fphar.2018.00021
   PubMed Web of Science ®Google Scholar
• Tyagi A, Agarwal C, Dwyer-Nield LD, Singh RP, Malkinson AM, Agarwal R. Silibinin modulates tnf-α and ifn-γ mediated signaling to regulate cox2 and inos expression in tumorigenic mouse lung epithelial lm2 cells. Mol Carcinog. 2012;51(10):832–42. doi:10.1002/mc.20851
   PubMed Web of Science ®Google Scholar
• Bosch-Barrera J, Queralt B, Menendez JA. Targeting stat3 with silibinin to improve cancer therapeutics. Cancer Treat Rev. 2017;58:61–9. doi:10.1016/j.ctrv.2017.06.003
   PubMed Web of Science ®Google Scholar
• Deep G, Kumar R, Nambiar DK, Jain AK, Ramteke AM, Serkova NJ, Agarwal C, Agarwal R. Silibinin inhibits hypoxia-induced hif-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics. Mol Carcinog. 2017;56(3):833–48. doi:10.1002/mc.22537
   PubMed Web of Science ®Google Scholar
• Prasad RR, Paudel S, Raina K, Agarwal R. Silibinin and non-melanoma skin cancers. J Tradit Complement Med. 2020;10(3):236–44. doi:10.1016/j.jtcme.2020.02.003
   PubMedGoogle Scholar
• Sherman B, Hernandez AM, Alhado M, Menge L, Price RS. Silibinin differentially decreases the aggressive cancer phenotype in an in vitro model of obesity and prostate cancer. Nutrition and Cancer. 2020;72(2):333–42. doi:10.1080/01635581.2019.1633363
   PubMed Web of Science ®Google Scholar
• Bosch-Barrera J, Sais E, Cañete N, Marruecos J, Cuyàs E, Izquierdo A, Porta R, Haro M, Brunet J, Pedraza S, et al. Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin. Oncotarget. 2016;7(22):32006–14. doi:10.18632/oncotarget.7900
   PubMedGoogle Scholar
• Shafabakhsh R, Asemi Z. Quercetin: A natural compound for ovarian cancer treatment. J Ovarian Res. 2019;12(1):55– doi:10.1186/s13048-019-0530-4
   PubMed Web of Science ®Google Scholar
• Tang S-M, Deng X-T, Zhou J, Li Q-P, Ge X-X, Miao L. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604. doi:10.1016/j.biopha.2019.109604
   PubMed Web of Science ®Google Scholar
• Chou C-C, Yang J-S, Lu H-F, Ip S-W, Lo C, Wu C-C, Lin J-P, Tang N-Y, Chung J-G, Chou M-J, et al. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer mcf-7 cells. Arch Pharm Res. 2010;33(8):1181–91. doi:10.1007/s12272-010-0808-y
   PubMed Web of Science ®Google Scholar
• Choi EJ, Bae SM, Ahn WS. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer mda-mb-453 cells. Arch Pharm Res. 2008;31(10):1281–5. doi:10.1007/s12272-001-2107-0
   PubMed Web of Science ®Google Scholar
• Niu G, Yin S, Xie S, Li Y, Nie D, Ma L, Wang X, Wu Y. Quercetin induces apoptosis by activating caspase-3 and regulating bcl-2 and cyclooxygenase-2 pathways in human hl-60 cells. Acta Biochim Biophys Sin (Shanghai). 2011;43(1):30–7. doi:10.1093/abbs/gmq107
   PubMed Web of Science ®Google Scholar
• Chien S-Y, Wu Y-C, Chung J-G, Yang J-S, Lu H-F, Tsou M-F, Wood WG, Kuo S-J, Chen D-R. Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer mda-mb-231 cells. Hum Exp Toxicol. 2009;28(8):493–503. doi:10.1177/0960327109107002
   PubMed Web of Science ®Google Scholar
• Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of bcl-2, and inhibition of pi-3-kinase/akt and erk pathways in a human hepatoma cell line (hepg2). J Nutr. 2006;136(11):2715–21. doi:10.1093/jn/136.11.2715
   PubMed Web of Science ®Google Scholar
• Reyes-Farias M, Carrasco-Pozo C. The anti-cancer effect of quercetin: Molecular implications in cancer metabolism. IJMS. 2019;20(13):3177. doi:10.3390/ijms20133177
   Web of Science ®Google Scholar
• Yuan Z, Long C, Junming T, Qihuan L, Youshun Z, Chan Z. Quercetin-induced apoptosis of hl-60 cells by reducing pi3k/akt. Mol Biol Rep. 2012;39(7):7785–93. doi:10.1007/s11033-012-1621-0
   PubMed Web of Science ®Google Scholar
• Cao H-H, Tse AK-W, Kwan H-Y, Yu H, Cheng C-Y, Su T, Fong W-F, Yu Z-L. Quercetin exerts anti-melanoma activities and inhibits stat3 signaling. Biochem Pharmacol. 2014;87(3):424–34. doi:10.1016/j.bcp.2013.11.008
   PubMed Web of Science ®Google Scholar
• Lu J, Wang Z, Li S, Xin Q, Yuan M, Li H, Song X, Gao H, Pervaiz N, Sun X, et al. Quercetin inhibits the migration and invasion of hcclm3 cells by suppressing the expression of p-akt1, matrix metalloproteinase (mmp) mmp-2, and mmp-9. Med Sci Monit. 2018;24:2583–9. doi:10.12659/MSM.906172
   PubMed Web of Science ®Google Scholar
• Kee J-Y, Han Y-H, Kim D-S, Mun J-G, Park J, Jeong M-Y, Um J-Y, Hong S-H. Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability. Phytomedicine. 2016;23(13):1680–90. doi:10.1016/j.phymed.2016.09.011
   PubMed Web of Science ®Google Scholar
• Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, Zhang F, Chen B, Zhou M. Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses il-6 induced epithelial-mesenchymal transition, expression of mmp by inhibiting stat3 signaling in pancreatic cancer cells. Onco Targets Ther. 2017;10:4719–29. doi:10.2147/OTT.S136840
   PubMed Web of Science ®Google Scholar
• Fan P, Zhang Y, Liu L, Zhao Z, Yin Y, Xiao X, Bauer N, Gladkich J, Mattern J, Gao C, et al. Continuous exposure of pancreatic cancer cells to dietary bioactive agents does not induce drug resistance unlike chemotherapy. Cell Death Dis. 2016;7(6):e2246-e2246. doi:10.1038/cddis.2016.157
   Web of Science ®Google Scholar
• Ren J, Lu Y, Qian Y, Chen B, Wu T, Ji G. Recent progress regarding kaempferol for the treatment of various diseases. Exp Ther Med. 2019;18(4):2759–76. doi:10.3892/etm.2019.7886
   PubMed Web of Science ®Google Scholar
• Yi X, Zuo J, Tan C, Xian S, Luo C, Chen S, Yu L, Luo Y. Kaempferol, a flavonoid compound from gynura medica induced apoptosis and growth inhibition in mcf-7 breast cancer cell. Afr J Tradit Complement Altern Med. 2016;13(4):210–5. doi:10.21010/ajtcam.v13i4.27
   PubMedGoogle Scholar
• Kim S-H, Hwang K-A, Choi K-C. Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem. 2016;28:70–82. doi:10.1016/j.jnutbio.2015.09.027
   PubMed Web of Science ®Google Scholar
• Wang X, Yang Y, An Y, Fang G. The mechanism of anticancer action and potential clinical use of kaempferol in the treatment of breast cancer. Biomed Pharmacother. 2019;117:109086. doi:10.1016/j.biopha.2019.109086
   PubMed Web of Science ®Google Scholar
• Cho HJ, Park JHY. Kaempferol induces cell cycle arrest in ht-29 human colon cancer cells. J Cancer Prev. 2013;18(3):257–63. doi:10.15430/jcp.2013.18.3.257
   PubMedGoogle Scholar
• Gao Y, Yin J, Rankin GO, Chen YC. Kaempferol induces g2/m cell cycle arrest via checkpoint kinase 2 and promotes apoptosis via death receptors in human ovarian carcinoma a2780/cp70 cells. Molecules. 2018;23(5):1095. doi:10.3390/molecules23051095
   PubMed Web of Science ®Google Scholar
• Kashyap D, Sharma A, Tuli HS, Sak K, Punia S, Mukherjee TK. Kaempferol - a dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J Funct Foods. 2017;30:203–19. doi:10.1016/j.jff.2017.01.022
   PubMed Web of Science ®Google Scholar
• Li S, Yan T, Deng R, Jiang X, Xiong H, Wang Y, Yu Q, Wang X, Chen C, Zhu Y. Low dose of kaempferol suppresses the migration and invasion of triple-negative breast cancer cells by downregulating the activities of rhoa and rac1. Onco Targets Ther. 2017;10:4809–19. doi:10.2147/OTT.S140886
   PubMed Web of Science ®Google Scholar
• Kim TW, Lee SY, Kim M, Cheon C, Ko S-G. Kaempferol induces autophagic cell death via ire1-jnk-chop pathway and inhibition of g9a in gastric cancer cells. Cell Death Dis. 2018;9(9):875. doi:10.1038/s41419-018-0930-1
   PubMed Web of Science ®Google Scholar
• Salmani JMM, Zhang X-P, Jacob JA, Chen B-A. Apigenin’s anticancer properties and molecular mechanisms of action: Recent advances and future prospectives. Chin J Nat Med. 2017;15(5):321–9. doi:10.1016/S1875-5364(17)30052-3
   PubMed Web of Science ®Google Scholar
• Yan X, Qi M, Li P, Zhan Y, Shao H. Apigenin in cancer therapy: Anti-cancer effects and mechanisms of action. Cell Biosci. 2017;7:50–doi:10.1186/s13578-017-0179-x
   PubMed Web of Science ®Google Scholar
• Sung B, Chung HY, Kim ND. Role of apigenin in cancer prevention via the induction of apoptosis and autophagy. J Cancer Prev. 2016;21(4):216–26. doi:10.15430/JCP.2016.21.4.216
   PubMedGoogle Scholar
• Shan S, Shi J, Yang P, Jia B, Wu H, Zhang X, Li Z. Apigenin restrains colon cancer cell proliferation via targeted blocking of pyruvate kinase m2-dependent glycolysis. J Agric Food Chem. 2017;65(37):8136–44. doi:10.1021/acs.jafc.7b02757
   PubMed Web of Science ®Google Scholar
• Du G-J, Zhang Z, Wen X-D, Yu C, Calway T, Yuan C-S, Wang C-Z. Epigallocatechin gallate (egcg) is the most effective cancer chemopreventive polyphenol in green tea. Nutrients. 2012;4(11):1679–91. doi:10.3390/nu4111679
   PubMed Web of Science ®Google Scholar
• Chen B-H, Hsieh C-H, Tsai S-Y, Wang C-Y, Wang C-C. Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of amp-activated protein kinase signaling pathway. Sci Rep. 2020;10(1):5163. doi:10.1038/s41598-020-62136-2
   PubMed Web of Science ®Google Scholar
• Negri A, Naponelli V, Rizzi F, Bettuzzi S. Molecular targets of epigallocatechin—gallate (egcg): A special focus on signal transduction and cancer. Nutrients. 2018;10(12):1936. doi:10.3390/nu10121936
   PubMed Web of Science ®Google Scholar
• Liu C, Li P, Qu Z, Xiong W, Liu A, Zhang S. Advances in the antagonism of epigallocatechin-3-gallate in the treatment of digestive tract tumors. Molecules. 2019;24(9):1726. doi:10.3390/molecules24091726
   PubMed Web of Science ®Google Scholar
• Yuan JH, Li YQ, Yang XY. Inhibition of epigallocatechin gallate on orthotopic colon cancer by upregulating the nrf2-ugt1a signal pathway in nude mice. Pharmacology. 2007;80(4):269–78. doi:10.1159/000106447
   PubMed Web of Science ®Google Scholar
• Min K-J, Kwon TK. Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate. Integr Med Res. 2014;3(1):16–24. doi:10.1016/j.imr.2013.12.001
   PubMedGoogle Scholar
• Wei R, Hackman RM, Wang Y, Mackenzie GG. Targeting glycolysis with epigallocatechin-3-gallate enhances the efficacy of chemotherapeutics in pancreatic cancer cells and xenografts. Cancers. 2019;11(10):1496. doi:10.3390/cancers11101496
   PubMed Web of Science ®Google Scholar
• Li K, Xiao G, Richardson JJ, Tardy BL, Ejima H, Huang W, Guo J, Liao X, Shi B. Targeted therapy against metastatic melanoma based on self-assembled metal-phenolic nanocomplexes comprised of green tea catechin. Adv Sci (Weinh). 2019;6(5):1801688. doi:10.1002/advs.201801688
   PubMedGoogle Scholar
• Ghanbari-Movahed M, Jackson G, Farzaei MH, Bishayee A. A systematic review of the preventive and therapeutic effects of naringin against human malignancies. Front Pharmacol. 2021;12:639840. doi:10.3389/fphar.2021.639840
   PubMed Web of Science ®Google Scholar
• Ahamad MS, Siddiqui S, Jafri A, Ahmad S, Afzal M, Arshad M. Induction of apoptosis and antiproliferative activity of naringenin in human epidermoid carcinoma cell through ros generation and cell cycle arrest. PLoS One. 2014;9(10):e110003. doi:10.1371/journal.pone.0110003
   PubMed Web of Science ®Google Scholar
• Song HM, Park GH, Eo HJ, Lee JW, Kim MK, Lee JR, Lee MH, Koo JS, Jeong JB. Anti-proliferative effect of naringenin through p38-dependent downregulation of cyclin d1 in human colorectal cancer cells. Biomol Ther (Seoul). 2015;23(4):339–44. doi:10.4062/biomolther.2015.024
   PubMed Web of Science ®Google Scholar
• Li Q, Wang Y, Zhang L, Chen L, Du Y, Ye T, Shi X. Naringenin exerts anti-angiogenic effects in human endothelial cells: Involvement of errα/vegf/kdr signaling pathway. Fitoterapia. 2016;111:78–86. doi:10.1016/j.fitote.2016.04.015
   PubMed Web of Science ®Google Scholar
• Gumushan Aktas H, Akgun T. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels. Biomed Pharmacother. 2018;106:770–5. doi:10.1016/j.biopha.2018.07.008
   PubMed Web of Science ®Google Scholar
• Krishnakumar N, Sulfikkarali N, RajendraPrasad N, Karthikeyan S. Enhanced anticancer activity of naringenin-loaded nanoparticles in human cervical (hela) cancer cells. Biomedicine & Preventive Nutrition. 2011;1(4):223–31. doi:10.1016/j.bionut.2011.09.003
   Google Scholar
• Fuster MG, Carissimi G, Montalbán MG, Víllora G. Improving anticancer therapy with naringenin-loaded silk fibroin nanoparticles. Nanomaterials. 2020;10(4):718. doi:10.3390/nano10040718
   Web of Science ®Google Scholar
• Alappat B, Alappat J. Anthocyanin pigments: Beyond aesthetics. Molecules. 2020;25(23):5500. doi:10.3390/molecules25235500
   PubMed Web of Science ®Google Scholar
• Wang Y, Lin J, Tian J, Si X, Jiao X, Zhang W, Gong E, Li B. Blueberry malvidin-3-galactoside suppresses hepatocellular carcinoma by regulating apoptosis, proliferation, and metastasis pathways in vivo and in vitro. J Agric Food Chem. 2019;67(2):625–36. doi:10.1021/acs.jafc.8b06209
   PubMed Web of Science ®Google Scholar
• Pan F, Liu Y, Liu J, Wang E. Stability of blueberry anthocyanin, anthocyanidin and pyranoanthocyanidin pigments and their inhibitory effects and mechanisms in human cervical cancer hela cells. RSC Adv. 2019;9(19):10842–53. doi:10.1039/c9ra01772k
   PubMed Web of Science ®Google Scholar
• Khoo HE, Azlan A, Tang ST, Lim SM. Anthocyanidins and anthocyanins: Colored pigments as food, pharmaceutical ingredients, and the potential health benefits. Food Nutr Res. 2017;61(1):1361779–doi:10.1080/16546628.2017.1361779
   PubMed Web of Science ®Google Scholar
• Shih P-H, Yeh C-T, Yen G-C. Effects of anthocyanidin on the inhibition of proliferation and induction of apoptosis in human gastric adenocarcinoma cells. Food and chemical toxicology: an international journal published for the British Industrial. Biological Research Association. 2005;43(10):1557–66. doi:10.1016/j.fct.2005.05.001
   Web of Science ®Google Scholar
• Lin J, Tian J, Shu C, Cheng Z, Liu Y, Wang W, Liu R, Li B, Wang Y. Malvidin-3-galactoside from blueberry suppresses the growth and metastasis potential of hepatocellular carcinoma cell huh-7 by regulating apoptosis and metastases pathways. Food Sci Hum Wellness. 2020;9(2):136–45. doi:10.1016/j.fshw.2020.02.004
   Google Scholar
• Varinska L, Gal P, Mojzisova G, Mirossay L, Mojzis J. Soy and breast cancer: Focus on angiogenesis. Int J Mol Sci. 2015;16(5):11728–49. doi:10.3390/ijms160511728
   PubMed Web of Science ®Google Scholar
• Banerjee S, Li Y, Wang Z, Sarkar FH. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008;269(2):226–42. doi:10.1016/j.canlet.2008.03.052
   PubMed Web of Science ®Google Scholar
• Tuli HS, Tuorkey MJ, Thakral F, Sak K, Kumar M, Sharma AK, Sharma U, Jain A, Aggarwal V, Bishayee A. Molecular mechanisms of action of genistein in cancer: Recent advances. Front Pharmacol. 2019;10:1336– doi:10.3389/fphar.2019.01336
   PubMed Web of Science ®Google Scholar
• Kashyap D, Sharma A, Tuli HS, Sak K, Punia S, Mukherjee TK. Kaempferol - a dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. (1756–4646 (Print)) J Funct Foods. 2017;203–19.
   Google Scholar
• Chae H-S, Xu R, Won J-Y, Chin Y-W, Yim H. Molecular targets of genistein and its related flavonoids to exert anticancer effects. IJMS. 2019;20(10):2420. doi:10.3390/ijms20102420
   Web of Science ®Google Scholar
• Donovan MG, Selmin OI, Doetschman TC, Romagnolo DF. Epigenetic activation of brca1 by genistein in vivo and triple negative breast cancer cells linked to antagonism toward aryl hydrocarbon receptor. Nutrients. 2019;11(11):2559. doi:10.3390/nu11112559
   PubMed Web of Science ®Google Scholar
• Chabot GG, Touil YS, Pham MH, Dauzonne D. Flavonoids in cancer prevention and therapy: Chemistry, pharmacology, mechanisms of action, and perspectives for cancer drug discovery. In: Alaoui-Jamali, M. (eds) Alternative and Complementary Therapies for Cancer. Springer, Boston, MA. 2010; 583–612. https://doi.org/10.1007/978-1-4419-0020-3_23
   Google Scholar
• Delmas D, Xiao J, Vejux A, Aires V. Silymarin and cancer: A dual strategy in both in chemoprevention and chemosensitivity. Molecules. 2020;25(9):2009. doi:10.3390/molecules25092009
   PubMed Web of Science ®Google Scholar
• Molavi O, Narimani F, Asiaee F, Sharifi S, Tarhriz V, Shayanfar A, Hejazi M, Lai R. Silibinin sensitizes chemo-resistant breast cancer cells to chemotherapy. Pharm Biol. 2017;55(1):729–39. doi:10.1080/13880209.2016.1270972
   PubMed Web of Science ®Google Scholar
• Ana Filipa B, Marina R, Ana Margarida A, Ana Salome P, Ricardo Jorge T, JG, TralhaoMaria, Filomena B. Quercetin in cancer treatment, alone or in combination with conventional therapeutics? Curr Med Chem. 2015;22(26):3025–39.
   PubMed Web of Science ®Google Scholar
• Lei C-S, Hou Y-C, Pai M-H, Lin M-T, Yeh S-L. Effects of quercetin combined with anticancer drugs on metastasis-associated factors of gastric cancer cells: In vitro and in vivo studies. J Nutr Biochem. 2018;51:105–13. doi:10.1016/j.jnutbio.2017.09.011
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang J, Yu C, Xiang L, Li L, Shi D, Lin F. Quercetin enhanced paclitaxel therapeutic effects towards pc-3 prostate cancer through er stress induction and ros production. Onco Targets Ther. 2020;13:513–23. doi:10.2147/OTT.S228453
   PubMed Web of Science ®Google Scholar
• Li S, Yuan S, Zhao Q, Wang B, Wang X, Li K. Quercetin enhances chemotherapeutic effect of doxorubicin against human breast cancer cells while reducing toxic side effects of it. Biomed Pharmacother. 2018;100:441–7. doi:10.1016/j.biopha.2018.02.055
   PubMed Web of Science ®Google Scholar
• Riahi-Chebbi I, Souid S, Othman H, Haoues M, Karoui H, Morel A, Srairi-Abid N, Essafi M, Essafi-Benkhadir K. The phenolic compound kaempferol overcomes 5-fluorouracil resistance in human resistant ls174 colon cancer cells. Sci Rep. 2019;9(1):195. doi:10.1038/s41598-018-36808-z
   PubMed Web of Science ®Google Scholar
• Luo H, Daddysman MK, Rankin GO, Jiang B-H, Chen YC. Kaempferol enhances cisplatin’s effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cmyc. Cancer Cell Int. 2010;10(1):16. doi:10.1186/1475-2867-10-16
   PubMed Web of Science ®Google Scholar
• Liu R, Ji P, Liu B, Qiao H, Wang X, Zhou L, Deng T, Ba Y. Apigenin enhances the cisplatin cytotoxic effect through p53-modulated apoptosis. Oncol Lett. 2017;13(2):1024–30. doi:10.3892/ol.2016.5495
   PubMed Web of Science ®Google Scholar
• Hu X-Y, Liang J-Y, Guo X-J, Liu L, Guo Y-B. 5-fluorouracil combined with apigenin enhances anticancer activity through mitochondrial membrane potential (δψm)-mediated apoptosis in hepatocellular carcinoma. Clin Exp Pharmacol Physiol. 2015;42(2):146–53. doi:10.1111/1440-1681.12333
   PubMed Web of Science ®Google Scholar
• Li K, Li M, Luo Z, Mao Y, Yu Y, He Y, Zhou J, Fei Y, Pei Y, Cai K. Overcoming the hypoxia-induced drug resistance in liver tumor by the concurrent use of apigenin and paclitaxel. Biochem Biophys Res Commun. 2020;526(2):321–7. doi:10.1016/j.bbrc.2020.03.010
   PubMed Web of Science ®Google Scholar
• Kumazoe M, Takai M, Hiroi S, Takeuchi C, Yamanouchi M, Nojiri T, Onda H, Bae J, Huang Y, Takamatsu K, et al. Pde3 inhibitor and egcg combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma. Sci Rep. 2017;7(1):1917. doi:10.1038/s41598-017-02162-9
   PubMed Web of Science ®Google Scholar
• La X, Zhang L, Li Z, Li H, Yang Y. −)-epigallocatechin gallate (egcg) enhances the sensitivity of colorectal cancer cells to 5-fu by inhibiting grp78/nf-κb/mir-155-5p/mdr1 pathway. J Agric Food Chem. 2019;67(9):2510–8. doi:10.1021/acs.jafc.8b06665
   PubMed Web of Science ®Google Scholar
• Zhang H, Zhong X, Zhang X, Shang D, Zhou YI, Zhang C. Enhanced anticancer effect of abt-737 in combination with naringenin on gastric cancer cells. Exp Ther Med. 2016;11(2):669–73. doi:10.3892/etm.2015.2912
   PubMed Web of Science ®Google Scholar
• Hatkevich T, Ramos J, Santos-Sanchez I, Patel YM. A naringenin–tamoxifen combination impairs cell proliferation and survival of mcf-7 breast cancer cells. Exp Cell Res. 2014;327(2):331–9. doi:10.1016/j.yexcr.2014.05.017
   PubMed Web of Science ®Google Scholar
• Park S-J, Kim M-J, Kim Y-K, Kim S-M, Park J-Y, Myoung H. Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma. Cancer Letters. 2010;292(1):54–63. doi:10.1016/j.canlet.2009.11.004
   PubMed Web of Science ®Google Scholar
• Sahin K, Tuzcu M, Basak N, Caglayan B, Kilic U, Sahin F, Kucuk O. Sensitization of cervical cancer cells to cisplatin by genistein: The role of nfκb and akt/mtor signaling pathways. Journal of Oncology. 2012;2012:1–6. doi:10.1155/2012/461562
   Google Scholar
• Suzuki R, Ya K, Li X, Roife D, Zhang R, Fleming JB. Genistein potentiates the antitumor effect of 5-fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells. Anticancer Res. 2014;34(9):4685–92.
   PubMed Web of Science ®Google Scholar
• Xue J-P, Wang G, Zhao Z-B, Wang Q, Shi Y. Synergistic cytotoxic effect of genistein and doxorubicin on drug-resistant human breast cancer mcf-7/adr cells. Oncol Rep. 2014;32(4):1647–53. doi:10.3892/or.2014.3365
   PubMed Web of Science ®Google Scholar
• Shukla RP, Dewangan J, Urandur S, Banala VT, Diwedi M, Sharma S, Agrawal S, Rath SK, Trivedi R, Mishra PR. Multifunctional hybrid nanoconstructs facilitate intracellular localization of doxorubicin and genistein to enhance apoptotic and anti-angiogenic efficacy in breast adenocarcinoma. Biomater Sci. 2020;8(5):1298–315. doi:10.1039/c9bm01246j
   PubMed Web of Science ®Google Scholar
• Yazdi Rouholamini SE, Moghassemi S, Maharat Z, Hakamivala A, Kashanian S, Omidfar K. Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on mirnas expression in 2d and 3d models of t47d breast cancer cell line. Artif Cells Nanomed Biotechnol. 2018;46(3):524–35. doi:10.1080/21691401.2017.1326928
   PubMed Web of Science ®Google Scholar
• Hossainzadeh S, Ranji N, Naderi Sohi A, Najafi F. Silibinin encapsulation in polymersome: A promising anticancer nanoparticle for inducing apoptosis and decreasing the expression level of mir-125b/mir-182 in human breast cancer cells. J Cell Physiol. 2019;234(12):22285–98. doi:10.1002/jcp.28795
   PubMed Web of Science ®Google Scholar
• Mahira S, Kommineni N, Husain GM, Khan W. Cabazitaxel and silibinin co-encapsulated cationic liposomes for cd44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomed Pharmacother. 2019;110:803–17. doi:10.1016/j.biopha.2018.11.145
   PubMed Web of Science ®Google Scholar
• Khakinezhad Tehrani F, Ranji N, Kouhkan F, Hosseinzadeh S. Apoptosis induction and proliferation inhibition by silibinin encapsulated in nanoparticles in mia paca-2 cancer cells and deregulation of some mirnas. Iran J Basic Med Sci. 2020;23(4):469–82. doi:10.22038/ijbms.2020.39427.9349
   PubMed Web of Science ®Google Scholar
• Baksi R, Singh DP, Borse SP, Rana R, Sharma V, Nivsarkar M. In vitro and in vivo anticancer efficacy potential of quercetin loaded polymeric nanoparticles. Biomed Pharmacother. 2018;106:1513–26. doi:10.1016/j.biopha.2018.07.106
   PubMed Web of Science ®Google Scholar
• Rashedi J, Ghorbani Haghjo A, Mesgari Abbasi M, Dastranj Tabrizi A, Yaqoubi S, Sanajou D, Ashrafi Jigheh Z, Namvaran A, Mohammadi A, Mohammadi Khoshraj J, et al. Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in wistar rats. Adv Pharm Bull. 2019;9(3):409–15. doi:10.15171/apb.2019.048
   PubMed Web of Science ®Google Scholar
• Hussain Y, Mirzaei S, Ashrafizadeh M, Zarrabi A, Hushmandi K, Khan H, Daglia M. Quercetin and its nano-scale delivery systems in prostate cancer therapy: Paving the way for cancer elimination and reversing chemoresistance. Cancers. 2021;13(7):1602. doi:10.3390/cancers13071602
   PubMed Web of Science ®Google Scholar
• Simon AT, Dutta D, Chattopadhyay A, Ghosh SS. Quercetin-loaded luminescent hydroxyapatite nanoparticles for theranostic application in monolayer and spheroid cultures of cervical cancer cell line in vitro. ACS Appl Biol Mater. 2021;4(5):4495–506. doi:10.1021/acsabm.1c00255
   PubMedGoogle Scholar
• Colombo M, Figueiró F, de Fraga Dias A, Teixeira HF, Battastini AMO, Koester LS. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro. Int J Pharm. 2018;543(1-2):214–23.
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Mondal L, Mukherjee B, Dutta L, Ehsan I, Debnath MC, Gaonkar RH, Pal MM, Majumdar S. Apigenin loaded nanoparticle delayed development of hepatocellular carcinoma in rats. Nanomedicine. 2018;14(6):1905–17. doi:10.1016/j.nano.2018.05.011
   PubMed Web of Science ®Google Scholar
• Ganguly S, Dewanjee S, Sen R, Chattopadhyay D, Ganguly S, Gaonkar R, Debnath MC. Apigenin-loaded galactose tailored plga nanoparticles: A possible strategy for liver targeting to treat hepatocellular carcinoma. Colloids Surf B Biointerfaces. 2021;204:111778. doi:10.1016/j.colsurfb.2021.111778
   PubMed Web of Science ®Google Scholar
• Liu R, Rong G, Liu Y, Huang W, He D, Lu R. Delivery of apigenin-loaded magnetic fe2o3/fe3o4@msio2 nanocomposites to a549 cells and their antitumor mechanism. Mater Sci Eng C Mater Biol Appl. 2021;120:111719. doi:10.1016/j.msec.2020.111719
   PubMed Web of Science ®Google Scholar
• Sen K, Banerjee S, Mandal M. Dual drug loaded liposome bearing apigenin and 5-fluorouracil for synergistic therapeutic efficacy in colorectal cancer. Colloids Surf B Biointerfaces. 2019;180:9–22. doi:10.1016/j.colsurfb.2019.04.035
   PubMed Web of Science ®Google Scholar
• Liang K, Chung JE, Gao SJ, Yongvongsoontorn N, Kurisawa M. Highly augmented drug loading and stability of micellar nanocomplexes composed of doxorubicin and poly(ethylene glycol)–green tea catechin conjugate for cancer therapy. Adv Mater. 2018;30(14):1706963. doi:10.1002/adma.201706963
   Web of Science ®Google Scholar
• Luo S, Wang Y, Shen S, Tang P, Liu Z, Zhang S, Wu D. Ir780-loaded hyaluronic acid@gossypol–fe(iii)–egcg infinite coordination polymer nanoparticles for highly efficient tumor photothermal/coordinated dual drugs synergistic therapy. Adv Funct Mater. 2021;31(24):2100954. doi:10.1002/adfm.202100954
   Web of Science ®Google Scholar
• Chaurasia S, Patel RR, Vure P, Mishra B. Potential of cationic-polymeric nanoparticles for oral delivery of naringenin: In vitro and in vivo investigations. J Pharm Sci. 2018;107(2):706–16. doi:10.1016/j.xphs.2017.10.006
   PubMed Web of Science ®Google Scholar
• Parashar P, Rathor M, Dwivedi M, Saraf SA. Hyaluronic acid decorated naringenin nanoparticles: Appraisal of chemopreventive and curative potential for lung cancer. Pharmaceutics. 2018;10(1):33. doi:10.3390/pharmaceutics10010033
   PubMed Web of Science ®Google Scholar
• Wadhwa R, Paudel KR, Chin LH, Hon CM, Madheswaran T, Gupta G, Panneerselvam J, Lakshmi T, Singh SK, Gulati M, et al. Anti-inflammatory and anticancer activities of naringenin-loaded liquid crystalline nanoparticles in vitro. J Food Biochem. 2021;45(1):e13572. doi:10.1111/jfbc.13572
   PubMed Web of Science ®Google Scholar
• Pool H, Campos-Vega R, Herrera-Hernández MG, García-Solis P, García-Gasca T, Sánchez IC, Luna-Bárcenas G, Vergara-Castañeda H. Development of genistein-pegylated silica hybrid nanomaterials with enhanced antioxidant and antiproliferative properties on ht29 human colon cancer cells. Am J Transl Res. 2018;10(8):2306–23.
   PubMed Web of Science ®Google Scholar
• Cai L, Yu R, Hao X, Ding X. Folate receptor-targeted bioflavonoid genistein-loaded chitosan nanoparticles for enhanced anticancer effect in cervical cancers. Nanoscale Res Lett. 2017;12(1):509. doi:10.1186/s11671-017-2253-z
   PubMed Web of Science ®Google Scholar
• Ghasemi Goorbandi R, Mohammadi MR, Malekzadeh K. Synthesizing efficacious genistein in conjugation with superparamagnetic fe3o4 decorated with bio-compatible carboxymethylated chitosan against acute leukemia lymphoma. Biomater Res. 2020;24(1):9. doi:10.1186/s40824-020-00187-2
   PubMedGoogle Scholar
• Jahanafrooz Z, Motameh N, Bakhshandeh B. Comparative evaluation of silibinin effects on cell cycling and apoptosis in human breast cancer mcf-7 and t47d cell lines. Asian Pac J Cancer Prev. 2016;17(5):2661–5.
   PubMedGoogle Scholar
• Si L, Fu J, Liu W, Hayashi T, Nie Y, Mizuno K, Hattori S, Fujisaki H, Onodera S, Ikejima T. Silibinin inhibits migration and invasion of breast cancer mda-mb-231 cells through induction of mitochondrial fusion. Mol Cell Biochem. 2020;463(1-2):189–201. doi:10.1007/s11010-019-03640-6
   PubMed Web of Science ®Google Scholar
• Iqbal MA, Chattopadhyay S, Siddiqui FA, Ur Rehman A, Siddiqui S, Prakasam G, Khan A, Sultana S, Bamezai RNK. Silibinin induces metabolic crisis in triple-negative breast cancer cells by modulating egfr-myc-txnip axis: Potential therapeutic implications. Febs J. 2021;288(2):471–85. doi:10.1111/febs.15353
   PubMed Web of Science ®Google Scholar
• Yu H-C, Chen L-J, Cheng K-C, Li Y-X, Yeh C-H, Cheng J-T. Silymarin inhibits cervical cancer cell through an increase of phosphatase and tensin homolog. Phytother Res. 2012;26(5):709–15. doi:10.1002/ptr.3618
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu J, Zhang P, Dai L, Wu Z, Wang L, Cao M, Jiang J. Silibinin induces g1 arrest, apoptosis and jnk/sapk upregulation in sw1990 human pancreatic cancer cells. Oncol Lett. 2018;15(6):9868–76. doi:10.3892/ol.2018.8541
   PubMed Web of Science ®Google Scholar
• Feng J, Song D, Jiang S, Yang X, Ding T, Zhang H, Luo J, Liao J, Yin Q. Quercetin restrains tgf-β1-induced epithelial–mesenchymal transition by inhibiting twist1 and regulating e-cadherin expression. Biochem Biophys Res Commun. 2018;498(1):132–8. doi:10.1016/j.bbrc.2018.02.044
   PubMed Web of Science ®Google Scholar
• Shen X, Si Y, Wang Z, Wang J, Guo Y, Zhang X. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of pi3k/akt signaling. Int J Mol Med. 2016;38(2):619–26. doi:10.3892/ijmm.2016.2625
   PubMed Web of Science ®Google Scholar
• Li H, Chen C. Quercetin has antimetastatic effects on gastric cancer cells via the interruption of upa/upar function by modulating nf-κb, pkc-δ, erk1/2, and ampkα. Integr Cancer Ther. 2018;17(2):511–23. doi:10.1177/1534735417696702
   PubMed Web of Science ®Google Scholar
• Nguyen TTT, Tran E, Nguyen TH, Do PT, Huynh TH, Huynh H. The role of activated mek-erk pathway in quercetin-induced growth inhibition and apoptosis in a549 lung cancer cells. Carcinogenesis. 2004;25(5):647–59. doi:10.1093/carcin/bgh052
   PubMed Web of Science ®Google Scholar
• Chang J-H, Lai S-L, Chen W-S, Hung W-Y, Chow J-M, Hsiao M, Lee W-J, Chien M-H. Quercetin suppresses the metastatic ability of lung cancer through inhibiting snail-dependent akt activation and snail-independent adam9 expression pathways. Biochimica et. Biophysica Acta (BBA) - Molecular Cell Research. 2017;1864(10):1746–58. doi:10.1016/j.bbamcr.2017.06.017
   PubMed Web of Science ®Google Scholar
• Ren M-X, Deng X-H, Ai F, Yuan G-Y, Song H-Y. Effect of quercetin on the proliferation of the human ovarian cancer cell line skov-3 in vitro. Exp Ther Med. 2015;10(2):579–83. doi:10.3892/etm.2015.2536
   PubMed Web of Science ®Google Scholar
• Teekaraman D, Elayapillai SP, Viswanathan MP, Jagadeesan A. Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in pa-1 cell line. Chem Biol Interact. 2019;300:91–100. doi:10.1016/j.cbi.2019.01.008
   PubMed Web of Science ®Google Scholar
• Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncol. 2018;16(1):108– doi:10.1186/s12957-018-1400-z
   PubMed Web of Science ®Google Scholar
• Tsai P-H, Cheng C-H, Lin C-Y, Huang Y-T, Lee L-T, Kandaswami CC, Lin Y-C, Lee KP-H, Hung C-C, Hwang J-J, et al. Dietary flavonoids luteolin and quercetin suppressed cancer stem cell properties and metastatic potential of isolated prostate cancer cells. Anticancer Res. 2016;36(12):6367–80. doi:10.21873/anticanres.11234
   PubMed Web of Science ®Google Scholar
• Choi EJ, Ahn WS. Kaempferol induced the apoptosis via cell cycle arrest in human breast cancer mda-mb-453 cells. Nutr Res Pract. 2008;2(4):322–5. doi:10.4162/nrp.2008.2.4.322
   PubMedGoogle Scholar
• Li C, Zhao Y, Yang D, Yu Y, Guo H, Zhao Z, Zhang B, Yin X. Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem Cell Biol. 2015;93(1):16–27. doi:10.1139/bcb-2014-0067
   PubMed Web of Science ®Google Scholar
• Kashafi E, Moradzadeh M, Mohamadkhani A, Erfanian S. Kaempferol increases apoptosis in human cervical cancer hela cells via pi3k/akt and telomerase pathways. Biomed Pharmacother. 2017;89:573–7. doi:10.1016/j.biopha.2017.02.061
   PubMed Web of Science ®Google Scholar
• Han X, Liu C-F, Gao N, Zhao J, Xu J. Kaempferol suppresses proliferation but increases apoptosis and autophagy by up-regulating microrna-340 in human lung cancer cells. Biomed Pharmacother. 2018;108:809–16. doi:10.1016/j.biopha.2018.09.087
   PubMed Web of Science ®Google Scholar
• Luo H, Rankin GO, Liu L, Daddysman MK, Jiang B-H, Chen YC. Kaempferol inhibits angiogenesis and vegf expression through both hif dependent and independent pathways in human ovarian cancer cells. Nutr Cancer. 2009;61(4):554–63. doi:10.1080/01635580802666281
   PubMed Web of Science ®Google Scholar
• Lee J, Kim JH. Kaempferol inhibits pancreatic cancer cell growth and migration through the blockade of egfr-related pathway in vitro. PLoS One. 2016;11(5):e0155264-e0155264. doi:10.1371/journal.pone.0155264
   Web of Science ®Google Scholar
• Scherbakov AM, Andreeva OE. Apigenin inhibits growth of breast cancer cells: The role of erα and her2/neu. Acta Naturae. 2015;7(3):133–9.
   PubMed Web of Science ®Google Scholar
• Hong J, Fristiohady A, Nguyen CH, Milovanovic D, Huttary N, Krieger S, Hong J, Geleff S, Birner P, Jäger W, et al. Apigenin and luteolin attenuate the breaching of mda-mb231 breast cancer spheroids through the lymph endothelial barrier in vitro. Front Pharmacol. 2018;9:220– doi:10.3389/fphar.2018.00220
   PubMed Web of Science ®Google Scholar
• Chen X, Xu H, Yu X, Wang X, Zhu X, Xu X. Apigenin inhibits in vitro and in vivo tumorigenesis in cisplatin-resistant colon cancer cells by inducing autophagy, programmed cell death and targeting m-tor/pi3k/akt signalling pathway. Journal of BUON: official Journal of the Balkan Union of Oncology. 2019;24(2):488–93.
   PubMed Web of Science ®Google Scholar
• Xu M, Wang S, Song YU, Yao J, Huang K, Zhu X. Apigenin suppresses colorectal cancer cell proliferation, migration and invasion via inhibition of the wnt/β-catenin signaling pathway. Oncol Lett. 2016;11(5):3075–80. doi:10.3892/ol.2016.4331
   PubMed Web of Science ®Google Scholar
• Shukla S, Kanwal R, Shankar E, Datt M, Chance MR, Fu P, MacLennan GT, Gupta S. Apigenin blocks ikkα activation and suppresses prostate cancer progression. Oncotarget. 2015;6(31):31216–32. doi:10.18632/oncotarget.5157
   PubMedGoogle Scholar
• Zan L, Chen Q, Zhang L, Li X. Epigallocatechin gallate (egcg) suppresses growth and tumorigenicity in breast cancer cells by downregulation of mir-25. Bioengineered. 2019;10(1):374–82. doi:10.1080/21655979.2019.1657327
   PubMed Web of Science ®Google Scholar
• Wei R, Mao L, Xu P, Zheng X, Hackman RM, Mackenzie GG, Wang Y. Suppressing glucose metabolism with epigallocatechin-3-gallate (egcg) reduces breast cancer cell growth in preclinical models. Food Funct. 2018;9(11):5682–96. doi:10.1039/c8fo01397g
   PubMed Web of Science ®Google Scholar
• Khiewkamrop P, Phunsomboon P, Richert L, Pekthong D, Srisawang P. Epistructured catechins, egcg and ec facilitate apoptosis induction through targeting de novo lipogenesis pathway in hepg2 cells. Cancer Cell Int. 2018;18(1):46. doi:10.1186/s12935-018-0539-6
   PubMed Web of Science ®Google Scholar
• Wei R, CortezPenso NE, Hackman RM, Wang Y, Mackenzie GG. Epigallocatechin-3-gallate (egcg) suppresses pancreatic cancer cell growth, invasion, and migration partly through the inhibition of akt pathway and epithelial–mesenchymal transition: Enhanced efficacy when combined with gemcitabine. Nutrients. 2019;11(8):1856. doi:10.3390/nu11081856
   PubMed Web of Science ®Google Scholar
• Zhao Z, Jin G, Ge Y, Guo Z. Naringenin inhibits migration of breast cancer cells via inflammatory and apoptosis cell signaling pathways. Inflammopharmacology. 2019;27(5):1021–36. doi:10.1007/s10787-018-00556-3
   PubMed Web of Science ®Google Scholar
• Liao ACH, Kuo CC, Huang YC, Yeh CW, Hseu YC, Liu JY, Hsu LS. Naringenin inhibits migration of bladder cancer cells through downregulation of akt and mmp‑2. Mol Med Rep. 2014;10(3):1531–6. doi:10.3892/mmr.2014.2375
   PubMed Web of Science ®Google Scholar
• Song HM, Park GH, Eo HJ, Jeong JB. Naringenin-mediated atf3 expression contributes to apoptosis in human colon cancer. Biomol Ther (Seoul). 2016;24(2):140–6. doi:10.4062/biomolther.2015.109
   PubMed Web of Science ®Google Scholar
• Lim W, Park S, Bazer FW, Song G. Naringenin-induced apoptotic cell death in prostate cancer cells is mediated via the pi3k/akt and mapk signaling pathways. J Cell Biochem. 2017;118(5):1118–31. doi:10.1002/jcb.25729
   PubMed Web of Science ®Google Scholar
• Chen C, Wang Y, Chen S, Ruan X, Liao H, Zhang Y, Sun J, Gao J, Deng G. Genistein inhibits migration and invasion of cervical cancer hela cells by regulating fak-paxillin and mapk signaling pathways. Taiwanese J Obstet Gynecol. 2020;59(3):403–8. doi:10.1016/j.tjog.2020.03.012
   PubMed Web of Science ®Google Scholar
• Zhou P, Wang C, Hu Z, Chen W, Qi W, Li A. Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a notch1/nf-κb/slug/e-cadherin pathway. BMC Cancer. 2017;17(1):813. doi:10.1186/s12885-017-3829-9
   PubMed Web of Science ®Google Scholar
• Bi Y-l, Min M, Shen W, Liu Y. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, g0/g1cell cycle arrest and regulation of stat3 signalling pathway. Phytomedicine. 2018;39:10–6. doi:10.1016/j.phymed.2017.12.001
   PubMed Web of Science ®Google Scholar
• Chiyomaru T, Yamamura S, Fukuhara S, Yoshino H, Kinoshita T, Majid S, Saini S, Chang I, Tanaka Y, Enokida H, et al. Genistein inhibits prostate cancer cell growth by targeting mir-34a and oncogenic hotair. PLoS One. 2013;8(8):e70372-e70372. doi:10.1371/journal.pone.0070372
   Web of Science ®Google Scholar
• Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am J Clin Nutr. 2014;100 Suppl 1(1):431S–6S. doi:10.3945/ajcn.113.071290
   PubMed Web of Science ®Google Scholar
• Tyagi AK, Agarwal C, Chan DCF, Agarwal R. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma mcf-7 and mda-mb468 cells. Oncol Rep. 2004;11(2):493–9. doi:10.3892/or.11.2.493
   PubMed Web of Science ®Google Scholar
• Dhanalakshmi S, Agarwal P, Glode LM, Agarwal R. Silibinin sensitizes human prostate carcinoma du145 cells to cisplatin- and carboplatin-induced growth inhibition and apoptotic death. Int J Cancer. 2003;106(5):699–705. doi:10.1002/ijc.11299
   PubMed Web of Science ®Google Scholar
• Li J, Li B, Xu WW, Chan KW, Guan XY, Qin YR, Lee NPY, Chan KT, Law S, Tsao SW, et al. Role of ampk signaling in mediating the anticancer effects of silibinin in esophageal squamous cell carcinoma. Expert Opin Ther Targets. 2016;20(1):7–18. doi:10.1517/14728222.2016.1121236
   PubMed Web of Science ®Google Scholar
• Yang J, Xing Z. 2020. Silibinin sensitizes cd133+ hepatocellular carcinoma cells to cisplatin treatment through suppression of opa1. Research Square.
   Google Scholar
• Tyagi AK, Singh RP, Agarwal C, Chan DCF, Agarwal R. Silibinin strongly synergizes human prostate carcinoma du145 cells to doxorubicin-induced growth inhibition, g2-m arrest, and apoptosis. Clin Cancer Res. 2002;8(11):3512–9.
   PubMed Web of Science ®Google Scholar
• Ho B-Y, Lin C-H, Apaya MK, Chao W-W, Shyur L-F. Silibinin and paclitaxel cotreatment significantly suppress the activity and lung metastasis of triple negative 4t1 mammary tumor cell in mice. Journal of Traditional and Complementary Medicine. 2012;2(4):301–11. doi:10.1016/S2225-4110(16)30116-X
   PubMedGoogle Scholar
• Zhang Y, Ge Y, Ping X, Yu M, Lou D, Shi W. Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines. Mol Med Rep. 2018;18(2):1835–41. doi:10.3892/mmr.2018.9129
   PubMed Web of Science ®Google Scholar
• Pashaei-Asl F, Pashaei-Asl R, Khodadadi K, Akbarzadeh A, Ebrahimie E, Pashaiasl M. Enhancement of anticancer activity by silibinin and paclitaxel combination on the ovarian cancer. Artif Cells Nanomed Biotechnol. 2018;46(7):1483–7. doi:10.1080/21691401.2017.1374281
   PubMed Web of Science ®Google Scholar
• Demiroglu-Zergeroglu A, Basara-Cigerim B, Kilic E, Yanikkaya-Demirel G. The investigation of effects of quercetin and its combination with cisplatin on malignant mesothelioma cells in vitro. J Biomed Biotechnol. 2010;2010:851589. doi:10.1155/2010/851589
   PubMedGoogle Scholar
• Demiroglu-Zergeroglu A, Ergene E, Ayvali N, Kuete V, Sivas H. Quercetin and cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells. BMC Complement Altern Med. 2016;16(1):281–doi:10.1186/s12906-016-1267-x
   PubMed Web of Science ®Google Scholar
• Daker M, Ahmad M, Khoo ASB. Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer Cell Int. 2012;12(1):34. doi:10.1186/1475-2867-12-34
   PubMed Web of Science ®Google Scholar
• Liu H, Lee JI, Ahn T-G. Effect of quercetin on the anti-tumor activity of cisplatin in emt6 breast tumor-bearing mice. Obstet Gynecol Sci. 2019;62(4):242–8. doi:10.5468/ogs.2019.62.4.242
   PubMedGoogle Scholar
• Xavier CPR, Lima CF, Rohde M, Pereira-Wilson C. Quercetin enhances 5-fluorouracil-induced apoptosis in msi colorectal cancer cells through p53 modulation. Cancer Chemother Pharmacol. 2011;68(6):1449–57. doi:10.1007/s00280-011-1641-9
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee EJ, Min KH, Hur GY, Lee SH, Lee SY, Kim JH, Shin C, Shim JJ, In KH, et al. Quercetin enhances chemosensitivity to gemcitabine in lung cancer cells by inhibiting heat shock protein 70 expression. Clin Lung Cancer. 2015;16(6):e235–e243. doi:10.1016/j.cllc.2015.05.006
   PubMed Web of Science ®Google Scholar
• Yang F, Song L, Wang H, Wang J, Xu Z, Xing N. Combination of quercetin and 2-methoxyestradiol enhances inhibition of human prostate cancer lncap and pc-3 cells xenograft tumor growth. PLoS One. 2015;10(5):e0128277-e0128277. doi:10.1371/journal.pone.0128277
   Web of Science ®Google Scholar
• Taylor MA, Khathayer F, Ray SK. Quercetin and sodium butyrate synergistically increase apoptosis in rat c6 and human t98g glioblastoma cells through inhibition of autophagy. Neurochem Res. 2019;44(7):1715–25. doi:10.1007/s11064-019-02802-8
   PubMed Web of Science ®Google Scholar
• Li Q, Wei L, Lin S, Chen Y, Lin J, Peng J. Synergistic effect of kaempferol and 5‑fluorouracil on the growth of colorectal cancer cells by regulating the pi3k/akt signaling pathway. Mol Med Rep. 2019;20(1):728–34. doi:10.3892/mmr.2019.10296
   PubMed Web of Science ®Google Scholar
• Choi EJ, Kim G-H. 5-fluorouracil combined with apigenin enhances anticancer activity through induction of apoptosis in human breast cancer mda-mb-453 cells. Oncol Rep. 2009;22(6):1533–7. doi:10.3892/or_00000598
   PubMed Web of Science ®Google Scholar
• Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L, Yin Z. Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One. 2011;6(12):e29169-e29169. doi:10.1371/journal.pone.0029169
   Web of Science ®Google Scholar
• Kumazoe M, Sugihara K, Tsukamoto S, Huang Y, Tsurudome Y, Suzuki T, Suemasu Y, Ueda N, Yamashita S, Kim Y, et al. 67-kda laminin receptor increases cgmp to induce cancer-selective apoptosis. J Clin Invest. 2013;123(2):787–99. doi:10.1172/JCI64768
   PubMed Web of Science ®Google Scholar
• Zhang L, Xie J, Gan R, Wu Z, Luo H, Chen X, Lu Y, Wu L, Zheng D. Synergistic inhibition of lung cancer cells by egcg and nf-κb inhibitor bay11-7082. J Cancer. 2019;10(26):6543–56. doi:10.7150/jca.34285
   PubMed Web of Science ®Google Scholar
• Kwak TW, Kim DH, Chung C-W, Lee HM, Kim CH, Jeong Y-I, Kang DH. Synergistic anticancer effects of vorinostat and epigallocatechin-3-gallate against hucc-t1 human cholangiocarcinoma cells. Evid Based Complement Alternat Med. 2013;2013:185158–doi:10.1155/2013/185158
   PubMed Web of Science ®Google Scholar
• Mazumder MEH, Beale P, Chan C, Yu JQ, Huq F. Epigallocatechin gallate acts synergistically in combination with cisplatin and designed < em > trans</em>-palladiums in ovarian cancer cells. Anticancer Res. 2012;32(11):4851.
   PubMed Web of Science ®Google Scholar
• Hwang J-T, Ha J, Park OJ. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of ampk and cox-2 signaling pathways. Biochem Biophys Res Commun. 2005;332(2):433–40. doi:10.1016/j.bbrc.2005.04.143
   PubMed Web of Science ®Google Scholar